NCT00027781View on ClinicalTrials.gov

MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy

PHASE2CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

August 31, 2001

Primary Completion Date

March 31, 2003

Conditions

Prostate Cancer

Interventions

DRUG

sabarubicin

Trial Locations (10)

13385

CHU de la Timone, Marseille

21079

Centre de Lutte Contre le Cancer, Georges-Francois Leclerc, Dijon

28041

Hospital Universitario 12 de Octubre, Madrid

33076

Institut Bergonie, Bordeaux

49100

Rabin Medical Center - Beilinson Campus, Petah Tikva

63011

Centre Jean Perrin, Clermont-Ferrand

75651

CHU Pitie-Salpetriere, Paris

B-2650

Universitair Ziekenhuis Antwerpen, Edegem

D-20246

Universitaets-Krankenhaus Eppendorf, Hamburg

CH-3010

Inselspital, Bern, Bern

All Listed Sponsors

lead

European Organisation for Research and Treatment of Cancer - EORTC

NETWORK

NCT00027781 - MEN-10755 in Treating Patients With Progressive Prostate Cancer That Has Not Responded to Hormone Therapy | Biotech Hunter | Biotech Hunter